Discovery, Development, and Mechanisms of Action of the Human CD38 Antibody Daratumumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery, Development, and Mechanisms of Action of the Human CD38 Antibody Daratumumab

Published:2018-04-16 Issue: Volume: Page:153-195
ISSN:
Container-title:Successful Drug Discovery
language:
Short-container-title:

Author:

Janmaat Maarten L.¹,van de Donk Niels W.C.J.²,van Bueren Jeroen Lammerts¹,Ahmadi Tahamtan³,Kate Sasser A.³,Jansson Richard K.³,Lokhorst Henk M.²,Parren Paul W.H.I.¹⁴

Affiliation:

1. Genmab; Yalelaan 60 3584 CM Utrecht The Netherlands

2. VU University Medical Center; Department of Hematology; Boelelaan 1117 1081 HV Amsterdam The Netherlands

3. Janssen Research and Development; Spring House PA USA

4. Leiden University Medical Center; Department of Immunohematology and Blood Transfusion; Leiden The Netherlands

Publisher

Wiley-VCH Verlag GmbH & Co. KGaA

Reference138 articles.

1. Targeting CD38 with daratumumab monotherapy in multiple myeloma;Lokhorst;N. Engl. J. Med.,2015

2. Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial;Lonial;Lancet,2016

3. Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma;Plesner;Blood,2016

4. Daratumumab, lenalidomide, and dexamethasone for multiple myeloma;Dimopoulos;N. Engl. J. Med.,2016

5. Daratumumab, bortezomib, and dexamethasone for multiple myeloma;Palumbo;N. Engl. J. Med.,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological bases of cancer immunotherapy;Expert Reviews in Molecular Medicine;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP